A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409



Sjoukje J C van der Stegen, Mohamad Hamieh, Michel Sadelain. Nat Rev Drug Discov 2015
Times Cited: 249




List of shared articles



Times cited

A metabolic switch to memory CAR T cells: Implications for cancer treatment.
Hosein Rostamian, Keyvan Fallah-Mehrjardi, Mohammad Khakpoor-Koosheh, John M Pawelek, Jamshid Hadjati, Christine E Brown, Hamid R Mirzaei. Cancer Lett 2021
2

CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities.
Maryam Akhoundi, Mahsa Mohammadi, Seyedeh Saeideh Sahraei, Mohsen Sheykhhasan, Nashmin Fayazi. Cell Oncol (Dordr) 2021
2

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma.
Deming Duan, Keke Wang, Cheng Wei, Dudu Feng, Yonghua Liu, Qingyan He, Xing Xu, Chunling Wang, Shuping Zhao, Leili Lv,[...]. Front Immunol 2021
0

CAR-T cell therapy: current limitations and potential strategies.
Robert C Sterner, Rosalie M Sterner. Blood Cancer J 2021
12

Strategies for Dodging the Obstacles in CAR T Cell Therapy.
Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Fatemeh Rahbarizadeh, Shahryar Khoshtinat Nikkhoi. Front Oncol 2021
4


Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Stephanie J Si Lim, Stephen A Grupp, Amanda M DiNofia. Pediatr Blood Cancer 2021
0

The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma.
Albert Oriol, Laura Abril, Anna Torrent, Gladys Ibarra, Josep-Maria Ribera. Ther Adv Hematol 2021
0

A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
3

The potential of CAR T cell therapy for prostate cancer.
Philipp Wolf, Jamal Alzubi, Christian Gratzke, Toni Cathomen. Nat Rev Urol 2021
0


Advances in CAR design.
Amanda Heard, Jufang Chang, John M Warrington, Nathan Singh. Best Pract Res Clin Haematol 2021
0

Methods to edit T cells for cancer immunotherapy.
Francesca Lucibello, Silvia Menegatti, Laurie Menger. Methods Enzymol 2020
0

Immunotherapy of multiple myeloma.
Simone A Minnie, Geoffrey R Hill. J Clin Invest 2020
22